Format

Send to

Choose Destination
Pediatr Nephrol. 2018 Apr;33(4):585-594. doi: 10.1007/s00467-017-3681-9. Epub 2017 May 15.

Survival in children requiring chronic renal replacement therapy.

Author information

1
ESPN/ERA-EDTA Registry, Department of Medical Informatics, Academic Medical Center, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, The Netherlands. n.c.chesnaye@amc.uva.nl.
2
Spaarne Gasthuis Academie, Spaarne Gasthuis, Hoofddorp, Netherlands.
3
ESPN/ERA-EDTA Registry, Department of Medical Informatics, Academic Medical Center, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, The Netherlands.
4
Department of Pediatrics, Bordeaux University Hospital and INSERM U1219, Bordeaux, France.
5
Department of Pediatric Nephrology, Emma Children's Hospital AMC, Amsterdam, Netherlands.

Abstract

Survival in the pediatric end-stage renal disease (ESRD) population has improved substantially over recent decades. Nonetheless, mortality remains at least 30 times higher than that of healthy peers. Patient survival is multifactorial and dependent on various patient and treatment characteristics and degree of economic welfare of the country in which a patient is treated. In this educational review, we aim to delineate current evidence regarding mortality risk in the pediatric ESRD population and provide pediatric nephrologists with up-to-date information required to counsel affected families.

KEYWORDS:

Children; End-stage renal disease; Global disparity; Mortality risk; Outcomes; Registry data

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center